These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 19429414)

  • 1. Polysaccharide nanogel delivery of a TNF-alpha and RANKL antagonist peptide allows systemic prevention of bone loss.
    Alles N; Soysa NS; Hussain MD; Tomomatsu N; Saito H; Baron R; Morimoto N; Aoki K; Akiyoshi K; Ohya K
    Eur J Pharm Sci; 2009 May; 37(2):83-8. PubMed ID: 19429414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tumor necrosis factor-alpha antagonist inhibits inflammatory bone resorption induced by Porphyromonas gingivalis infection in mice.
    Suzuki Y; Aoki K; Saito H; Umeda M; Nitta H; Baron R; Ohya K
    J Periodontal Res; 2006 Apr; 41(2):81-91. PubMed ID: 16499710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanogel-crosslinked nanoparticles increase the inhibitory effects of W9 synthetic peptide on bone loss in a murine bone resorption model.
    Sato T; Alles N; Khan M; Nagano K; Takahashi M; Tamura Y; Shimoda A; Ohya K; Akiyoshi K; Aoki K
    Int J Nanomedicine; 2015; 10():3459-73. PubMed ID: 25999711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanogel-based delivery system enhances PGE2 effects on bone formation.
    Kato N; Hasegawa U; Morimoto N; Saita Y; Nakashima K; Ezura Y; Kurosawa H; Akiyoshi K; Noda M
    J Cell Biochem; 2007 Aug; 101(5):1063-70. PubMed ID: 17520665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Osteoconductive Ability of Two Types of Cholesterol-Bearing Pullulan (CHP) Nanogel-Hydrogels Impregnated with BMP-2 and RANKL-Binding Peptide: Bone Histomorphometric Study in a Murine Calvarial Defect Model.
    Xie C; Rashed F; Sasaki Y; Khan M; Qi J; Kubo Y; Matsumoto Y; Sawada S; Sasaki Y; Ono T; Ikeda T; Akiyoshi K; Aoki K
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanogel DDS enables sustained release of IL-12 for tumor immunotherapy.
    Shimizu T; Kishida T; Hasegawa U; Ueda Y; Imanishi J; Yamagishi H; Akiyoshi K; Otsuji E; Mazda O
    Biochem Biophys Res Commun; 2008 Mar; 367(2):330-5. PubMed ID: 18158918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of interleukin-6 receptor directly blocks osteoclast formation in vitro and in vivo.
    Axmann R; Böhm C; Krönke G; Zwerina J; Smolen J; Schett G
    Arthritis Rheum; 2009 Sep; 60(9):2747-56. PubMed ID: 19714627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploitation of a novel polysaccharide nanogel cross-linking membrane for guided bone regeneration (GBR).
    Miyahara T; Nyan M; Shimoda A; Yamamoto Y; Kuroda S; Shiota M; Akiyoshi K; Kasugai S
    J Tissue Eng Regen Med; 2012 Aug; 6(8):666-72. PubMed ID: 22095663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of refolding activities between nanogel artificial chaperone and GroEL systems.
    Asayama W; Sawada S; Taguchi H; Akiyoshi K
    Int J Biol Macromol; 2008 Apr; 42(3):241-6. PubMed ID: 18179818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alpha-isoform of p38 MAPK specifically regulates arthritic bone loss.
    Böhm C; Hayer S; Kilian A; Zaiss MM; Finger S; Hess A; Engelke K; Kollias G; Krönke G; Zwerina J; Schett G; David JP
    J Immunol; 2009 Nov; 183(9):5938-47. PubMed ID: 19828631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perforated Hydrogels Consisting of Cholesterol-Bearing Pullulan (CHP) Nanogels: A Newly Designed Scaffold for Bone Regeneration Induced by RANKL-Binding Peptides and BMP-2.
    Xie C; Satake-Ozawa M; Rashed F; Khan M; Ikeda M; Hayashi S; Sawada S; Sasaki Y; Ikeda T; Mori Y; Akiyoshi K; Aoki K
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor.
    Hayashi C; Hasegawa U; Saita Y; Hemmi H; Hayata T; Nakashima K; Ezura Y; Amagasa T; Akiyoshi K; Noda M
    J Cell Physiol; 2009 Jul; 220(1):1-7. PubMed ID: 19301257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis.
    Schett G; Stolina M; Dwyer D; Zack D; Uderhardt S; Krönke G; Kostenuik P; Feige U
    Arthritis Rheum; 2009 Sep; 60(9):2644-54. PubMed ID: 19714640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heat shock protein 60 causes osteoclastic bone resorption via toll-like receptor-2 in estrogen deficiency.
    Koh JM; Lee YS; Kim YS; Park SH; Lee SH; Kim HH; Lee MS; Lee KU; Kim GS
    Bone; 2009 Oct; 45(4):650-60. PubMed ID: 19527807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct effects of osteoprotegerin on human bone cell metabolism.
    Grundt A; Grafe IA; Liegibel U; Sommer U; Nawroth P; Kasperk C
    Biochem Biophys Res Commun; 2009 Nov; 389(3):550-5. PubMed ID: 19748486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled dextrin nanogel as protein carrier: controlled release and biological activity of IL-10.
    Carvalho V; Castanheira P; Madureira P; Ferreira SA; Costa C; Teixeira JP; Faro C; Vilanova M; Gama M
    Biotechnol Bioeng; 2011 Aug; 108(8):1977-86. PubMed ID: 21391205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanism of NFATc1 in RANKL-induced osteoclast activation.
    Song I; Kim JH; Kim K; Jin HM; Youn BU; Kim N
    FEBS Lett; 2009 Jul; 583(14):2435-40. PubMed ID: 19576893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Orchiectomy upregulates free soluble RANKL in bone marrow of aged rats.
    Proell V; Xu H; Schüler C; Weber K; Hofbauer LC; Erben RG
    Bone; 2009 Oct; 45(4):677-81. PubMed ID: 19501680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early acceleration phase and late stationary phase of remodeling imbalance in long bones of male rats exposed to long-standing acidemia: a 10-month longitudinal study using bone histomorphometry.
    Assapun J; Charoenphandhu N; Krishnamra N
    Calcif Tissue Int; 2009 Jul; 85(1):1-9. PubMed ID: 19458886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha potentiates RhoA-mediated monocyte transmigratory activity in vivo at a picomolar level.
    Lim S; Ryu J; Shin JA; Shin MJ; Ahn YK; Kim JJ; Han KH
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2138-45. PubMed ID: 19745197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.